アルブミンを基盤としたドラッグデリバリーシステムの構造駆動設計
Xueer Zhou1, Yue Wang1, Sijian Yu1
1State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, Sichuan, China.
Advances in colloid and interface science
|February 25, 2026
まとめ
アルブミンを基盤としたドラッグデリバリーシステムはアルブミンを活用する
科学分野:
- 生体材料科学
- ドラッグデリバリー
- タンパク質工学
背景:
- アルブミンは、優れた生体適合性と長い半減期を持つ主要な血漿タンパク質です。
- アルブミンを基盤としたドラッグデリバリーシステムは広く研究されていますが、新たな視点が必要です。
- 既存の文献は、高度なアルブミンキャリア設計のために再検討する必要があります。
研究 の 目的:
- 構造駆動の観点からアルブミンが治療用分子を収容するメカニズムを分析すること。
- 薬物負荷戦略とアルブミンの階層的構造を結びつけること。
- 次世代のアルブミンベースのドラッグデリバリーシステムを設計するためのフレームワークを提供すること。
主な方法:
- 既存の文献の包括的な分析。
- アルブミンの階層的構造(αヘリカルドメイン、疎水性サブドメイン、構造的可塑性)に焦点を当てた構造駆動の視点。
- 物理吸着、共有結合、タンパク質コロナ形成、および再折り畳み支援カプセル化を含む薬物負荷アプローチの詳細な検討。
主要な成果:
- 異なる薬物負荷戦略は、アルブミンの構造的特徴と本質的に結びついています。
- 各負荷戦略の化学的原理と構造決定要因を理解することが不可欠です。
- アルブミンの階層的構造は、多様な治療用分子を収容する能力を決定します。
結論:
- 構造に焦点を当てた理解は、アルブミン薬物送達のための統一されたフレームワークを提供します。
- このフレームワークは、負荷、安定性、および放出プロファイルを改善したアルブミンキャリアの合理的な設計を導くことができます。
- 構造的洞察を通じたアルブミンキャリアの最適化は、臨床的応用を強化することができます。
関連する概念動画
Modified-Release Drug Delivery Systems: Rate-Programmed II
50
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
50
Modified-Release Drug Delivery Systems: Site-Targeted
51
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
51
Site-Targeted Drug Delivery Systems: Polymeric Carriers
59
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
59
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
62
Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...
62
Biopharmaceutical Factors Influencing Drug Product Design: Overview
382
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
382
Modified-Release Drug Delivery Systems: Stimuli-Activated
53
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
53


